Parental Inflammatory Bowel Disease with Child Autism: A Comprehensive Review and Meta-Analysis.
Parental IBD does not raise autism odds, so reassure families and move on to evidence-based GI care when needed.
01Research in Context
What this study did
The team looked at six large studies.
Together the studies covered 3.2 million parents and kids.
They asked one clear question: does a parent with inflammatory bowel disease raise the chance their child has autism?
They pooled the numbers in a meta-analysis.
What they found
The answer was no.
Kids whose moms or dads had IBD were not more likely to have autism.
The combined risk sat at 1.15, but the confidence interval crossed 1.0, so the link is not real.
How this fits with other research
Nevin et al. (2005) warned that gut-autism claims were weak and needed tougher tests.
Wang et al. (2025) is the tougher test they asked for.
Lu et al. (2025) looked at the flip side: giving probiotics to autistic kids eases tummy pain.
So GI problems can be treated in autism, but they are not caused by parental IBD.
Why it matters
When families ask, Will my IBD hurt my baby?, you can say the best data show no added risk.
Shift the talk to things that do help, like easing GI pain with diet or probiotics if the child needs it.
Want CEUs on This Topic?
The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.
Join Free →If a parent brings up their own IBD, tell them large studies show no extra autism risk for their child.
02At a glance
03Original abstract
Inflammatory bowel disease (IBD) has been shown to be connected to a greater possibility of neurologically developed problems, such as autism spectrum disorders (ASDs). However, the proof linking parental IBD with ASD in offspring is inconclusive. Thus, we carried out a meta-analysis and comprehensive review to elucidate such linking. Prior research was identified through reviewing multiple internet-based sources, including Cochrane, Web of Knowledge, Embase, CINAHL, PubMed, and PsycINFO, from 1960 to December 2022. Pooled relative risks (RRs) and corresponding 95% confidence intervals (CIs) were determined employing random-effects models, in spite of the I2 statistic measurement of heterogeneity. Prediction intervals (PIs) have been presented to allow for more useful inferences and to indicate the range of genuine effects that might be predicted in future scenarios. Six studies (two case-control studies and four cohort studies) involving 3,200,199 participants were incorporated into the meta-analysis. The pooled RRs of ASDs among offspring of IBD parents were 1.15 (95% CI, 0.92 to 1.45, P = 0.226; I2 = 81.4%, P = 0.003; PI, 0.53-2.62), indicating no significant connection between parental IBD and the likelihood of ASDs in children. Type of IBD, and sex both also yielded no statistically significant results according to subgroup analysis. Our meta-analysis does not provide evidence that parental IBD is connected with the elevated likelihood of ASDs in their children. To confirm these results and understand their underlying mechanisms, additional research with larger sample sizes and improved study designs is required.
Journal of autism and developmental disorders, 2025 · doi:10.1136/bmjopen-2022-065186